Category: Life Sciences
Life Sciences market research reports by Plunkett Research, Ltd.
-
Financial Analysis and Multi-Year Benchmarking: Turnstone Biologics Corp (TSBX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Turnstone Biologics Corp (TSBX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Turnstone Biologics Corp (TSBX:NAS). Includes Industry Av ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Vertex Inc (VERX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Vertex Inc (VERX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Vertex Inc (VERX:NAS). Includes Industry Averages & Top Competitors, KP ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Recursion Pharmaceuticals Inc (RXRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Recursion Pharmaceuticals Inc (RXRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Recursion Pharmaceuticals Inc (RXRX:NAS). Includes I ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Lyell Immunopharma Inc (LYEL:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Lyell Immunopharma Inc (LYEL:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Lyell Immunopharma Inc (LYEL:NAS). Includes Industry Averag ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Ocugen Inc (OCGN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Ocugen Inc (OCGN:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Ocugen Inc (OCGN:NAS). Includes Industry Averages & Top Competitors, KP ... Read More
-
Financial Analysis and Multi-Year Benchmarking: ARS Pharmaceuticals Inc (SPRY:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: ARS Pharmaceuticals Inc (SPRY:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: ARS Pharmaceuticals Inc (SPRY:NAS). Includes Industry Aver ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Kronos Bio Inc (KRON:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Kronos Bio Inc (KRON:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Kronos Bio Inc (KRON:NAS). Includes Industry Averages & Top Competi ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Phathom Pharmaceuticals Inc (PHAT:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Phathom Pharmaceuticals Inc (PHAT:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Phathom Pharmaceuticals Inc (PHAT:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Xeris Pharmaceuticals Inc (XERS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Xeris Pharmaceuticals Inc (XERS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Xeris Pharmaceuticals Inc (XERS:NAS). Includes Industry ... Read More
-
Financial Analysis and Multi-Year Benchmarking: 60 Degrees Pharmaceuticals Inc (SXTP:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: 60 Degrees Pharmaceuticals Inc (SXTP:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: 60 Degrees Pharmaceuticals Inc (SXTP:NAS). Includes ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Singular Genomics Systems Inc (OMIC:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Singular Genomics Systems Inc (OMIC:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Singular Genomics Systems Inc (OMIC:NAS). Includes I ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Foghorn Therapeutics Inc (FHTX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Foghorn Therapeutics Inc (FHTX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Foghorn Therapeutics Inc (FHTX:NAS). Includes Industry Av ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Organon and Co (OGN:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Organon and Co (OGN:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Organon and Co (OGN:NYS). Includes Industry Averages & Top Competito ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Acutus Medical Inc (AFIB:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Acutus Medical Inc (AFIB:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Acutus Medical Inc (AFIB:NAS). Includes Industry Averages & Top ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Lipella Pharmaceuticals Inc (LIPO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Lipella Pharmaceuticals Inc (LIPO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Lipella Pharmaceuticals Inc (LIPO:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Zevra Therapeutics Inc (ZVRA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Zevra Therapeutics Inc (ZVRA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Zevra Therapeutics Inc (ZVRA:NAS). Includes Industry Averag ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Tarsus Pharmaceuticals Inc (TARS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Tarsus Pharmaceuticals Inc (TARS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Tarsus Pharmaceuticals Inc (TARS:NAS). Includes Industr ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Verrica Pharmaceuticals Inc (VRCA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Verrica Pharmaceuticals Inc (VRCA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Verrica Pharmaceuticals Inc (VRCA:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Cytek Biosciences Inc (CTKB:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Cytek Biosciences Inc (CTKB:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Cytek Biosciences Inc (CTKB:NAS). Includes Industry Averages ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Caribou Biosciences Inc (CRBU:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Caribou Biosciences Inc (CRBU:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Caribou Biosciences Inc (CRBU:NAS). Includes Industry Aver ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Lumos Pharma Inc (LUMO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Lumos Pharma Inc (LUMO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Lumos Pharma Inc (LUMO:NAS). Includes Industry Averages & Top Com ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Amylyx Pharmaceuticals Inc (AMLX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Amylyx Pharmaceuticals Inc (AMLX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Amylyx Pharmaceuticals Inc (AMLX:NAS). Includes Industr ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Kineta Inc (KA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Kineta Inc (KA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Kineta Inc (KA:NAS). Includes Industry Averages & Top Competitors, KPIs, ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Royalty Pharma PLC (RPRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Royalty Pharma PLC (RPRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Royalty Pharma PLC (RPRX:NAS). Includes Industry Averages & Top ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Petros Pharmaceuticals Inc (PTPI:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Petros Pharmaceuticals Inc (PTPI:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Petros Pharmaceuticals Inc (PTPI:NAS). Includes Industr ... Read More